14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CNAT
Delisted

Conatus Pharmaceuticals Inc. Stock Price (Quote)

$0.255
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.255 $0.255 Friday, 27th May 2022 CNAT stock ended at $0.255. During the day the stock fluctuated 0% from a day low at $0.255 to a day high of $0.255.
90 days $0.238 $0.275
52 weeks $0.203 $1.23

Historical Conatus Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Apr 27, 2021 $1.07 $1.08 $1.04 $1.04 394 849
Apr 26, 2021 $1.02 $1.08 $1.02 $1.07 592 056
Apr 23, 2021 $1.03 $1.07 $1.01 $1.02 243 435
Apr 22, 2021 $1.16 $1.16 $0.99 $1.02 654 091
Apr 21, 2021 $0.95 $1.00 $0.95 $0.99 527 861
Apr 20, 2021 $0.95 $0.97 $0.92 $0.95 513 850
Apr 19, 2021 $1.02 $1.05 $0.94 $0.95 1 396 506
Apr 16, 2021 $1.06 $1.07 $1.02 $1.03 991 613
Apr 15, 2021 $1.09 $1.14 $1.08 $1.10 798 471
Apr 14, 2021 $1.06 $1.11 $1.06 $1.08 381 497
Apr 13, 2021 $1.11 $1.12 $1.05 $1.06 645 624
Apr 12, 2021 $1.18 $1.19 $1.10 $1.10 956 918
Apr 09, 2021 $1.21 $1.24 $1.17 $1.17 492 234
Apr 08, 2021 $1.23 $1.25 $1.20 $1.22 387 551
Apr 07, 2021 $1.22 $1.23 $1.18 $1.19 395 732
Apr 06, 2021 $1.23 $1.26 $1.19 $1.23 597 509
Apr 05, 2021 $1.30 $1.30 $1.22 $1.25 689 245
Apr 01, 2021 $1.30 $1.31 $1.23 $1.30 782 205
Mar 31, 2021 $1.18 $1.32 $1.17 $1.30 1 155 214
Mar 30, 2021 $1.16 $1.16 $1.10 $1.13 685 710
Mar 29, 2021 $1.31 $1.31 $1.15 $1.15 819 514
Mar 26, 2021 $1.29 $1.29 $1.20 $1.23 674 241
Mar 25, 2021 $1.18 $1.29 $1.17 $1.27 780 806
Mar 24, 2021 $1.26 $1.29 $1.11 $1.22 2 071 573
Mar 23, 2021 $1.38 $1.39 $1.27 $1.27 1 490 226
Click to get the best stock tips daily for free!

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... CNAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT